Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 5,867,000 | 7,103,000 | 4,979,000 | 1,055,000 |
| Marketable Securities | N/A | 177,000 | 657,000 | 1,624,000 | 4,091,000 |
| Receivables | N/A | 6,668,000 | 5,561,000 | 4,778,000 | 6,274,000 |
| Inventories | N/A | 2,119,000 | 2,250,000 | 2,206,000 | 3,020,000 |
| Other current assets | 2,581,000 | 2,251,000 | 1,365,000 | 183,000 | 0 |
| TOTAL | $2,581,000 | $17,082,000 | $16,936,000 | $13,770,000 | $14,440,000 |
| Non-Current Assets | |||||
| PPE Net | N/A | 8,298,000 | 7,453,000 | 6,985,000 | 8,083,000 |
| Investments And Advances | 156,000 | 182,000 | 119,000 | 256,000 | 267,000 |
| Other Non-Current Assets | 23,433,000 | 22,395,000 | 5,424,000 | 3,829,000 | 2,826,000 |
| TOTAL | $23,589,000 | $30,875,000 | $12,996,000 | $11,070,000 | $11,176,000 |
| Total Assets | $26,170,000 | $47,957,000 | $29,932,000 | $24,840,000 | $25,616,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,178,000 | 6,968,000 | 6,334,000 | 5,466,000 | 7,640,000 |
| Other current liabilities | 600,000 | 387,000 | 0 | 0 | 0 |
| TOTAL | $13,320,000 | $15,187,000 | $9,447,000 | $6,839,000 | $7,782,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 10,876,000 | 1,087,000 | 1,111,000 | 1,030,000 |
| aiOther Non-Current Liabilities | 3,423,000 | 2,997,000 | 2,535,000 | 2,181,000 | 2,285,000 |
| TOTAL | $6,549,000 | $17,992,000 | $5,181,000 | $4,404,000 | $3,315,000 |
| Total Liabilities | $19,869,000 | $33,179,000 | $14,628,000 | $11,243,000 | $11,097,000 |
| Shareholders' Equity | |||||
| Common Shares | 362,000 | 364,000 | 383,000 | 395,000 | 411,000 |
| Retained earnings | N/A | 12,002,000 | 13,250,000 | 12,510,000 | 11,606,000 |
| Other shareholders' equity | 581,000 | 524,000 | 0 | 0 | 1,952,000 |
| TOTAL | $2,989,000 | $14,778,000 | $15,304,000 | $13,597,000 | $14,519,000 |
| Total Liabilities And Equity | $22,858,000 | $47,957,000 | $29,932,000 | $24,840,000 | $25,616,000 |